LAPTM4B and breast carcinoma: These results were consistent with previous studies that LAPTM4B could be a diagnostic, prognostic and therapeutic factor in hepatocellular carcinoma, breast cancer, hepatocellular carcinoma, bladder cancer and renal cell carcinoma and so on (17, 18, 30–38).